Diagnostic Medical (France) Performance
| ALDMS Stock | 1.01 0.06 6.32% |
On a scale of 0 to 100, Diagnostic Medical holds a performance score of 8. The firm shows a Beta (market volatility) of -0.0119, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Diagnostic Medical are expected to decrease at a much lower rate. During the bear market, Diagnostic Medical is likely to outperform the market. Please check Diagnostic Medical's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Diagnostic Medical's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Diagnostic Medical Systems are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Diagnostic Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -2.7 M |
Diagnostic |
Diagnostic Medical Relative Risk vs. Return Landscape
If you would invest 80.00 in Diagnostic Medical Systems on November 18, 2024 and sell it today you would earn a total of 21.00 from holding Diagnostic Medical Systems or generate 26.25% return on investment over 90 days. Diagnostic Medical Systems is generating 0.4619% of daily returns and assumes 4.3602% volatility on return distribution over the 90 days horizon. Simply put, 38% of stocks are less volatile than Diagnostic, and 91% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Diagnostic Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Diagnostic Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Diagnostic Medical Systems, and traders can use it to determine the average amount a Diagnostic Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1059
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALDMS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.36 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Diagnostic Medical is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Diagnostic Medical by adding it to a well-diversified portfolio.
Diagnostic Medical Fundamentals Growth
Diagnostic Stock prices reflect investors' perceptions of the future prospects and financial health of Diagnostic Medical, and Diagnostic Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Diagnostic Stock performance.
| Return On Equity | -0.39 | |||
| Return On Asset | -0.0452 | |||
| Profit Margin | (0.18) % | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 29.12 M | |||
| Shares Outstanding | 16.12 M | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 0.40 X | |||
| Revenue | 36.96 M | |||
| EBITDA | (4.6 M) | |||
| Total Debt | 10.03 M | |||
| Book Value Per Share | 1.17 X | |||
| Cash Flow From Operations | (1.08 M) | |||
| Earnings Per Share | (0.43) X | |||
| Total Asset | 53.03 M | |||
About Diagnostic Medical Performance
Assessing Diagnostic Medical's fundamental ratios provides investors with valuable insights into Diagnostic Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Diagnostic Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Diagnostic Medical performance evaluation
Checking the ongoing alerts about Diagnostic Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Diagnostic Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Diagnostic Medical has some characteristics of a very speculative penny stock | |
| Diagnostic Medical had very high historical volatility over the last 90 days | |
| Diagnostic Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 36.96 M. Net Loss for the year was (4.72 M) with profit before overhead, payroll, taxes, and interest of 15.22 M. | |
| Diagnostic Medical generates negative cash flow from operations | |
| About 20.0% of the company shares are held by company insiders |
- Analyzing Diagnostic Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Diagnostic Medical's stock is overvalued or undervalued compared to its peers.
- Examining Diagnostic Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Diagnostic Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Diagnostic Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Diagnostic Medical's stock. These opinions can provide insight into Diagnostic Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Diagnostic Stock Analysis
When running Diagnostic Medical's price analysis, check to measure Diagnostic Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnostic Medical is operating at the current time. Most of Diagnostic Medical's value examination focuses on studying past and present price action to predict the probability of Diagnostic Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnostic Medical's price. Additionally, you may evaluate how the addition of Diagnostic Medical to your portfolios can decrease your overall portfolio volatility.